ABBV vs DIS: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and The Walt Disney Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
The Walt Disney Company · Communication Services
$96.16
+45.0% upside to fair value
Grade B
QuantHub Verdict
DIS has more upside to fair value
(+45.0%).
DIS trades at a lower forward P/E
(15.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
DIS |
| Current Price |
$261.07 |
$96.16 |
| Fair Value Estimate |
$264.30 |
$139.43 |
| Upside to Fair Value |
+1.2%
|
+45.0%
|
| Market Cap |
$461.3B |
$167.0B |
| Forward P/E |
128.0x
|
15.4x
|
| EV / EBITDA |
31.0x
|
10.8x
|
| Price / Sales |
7.3x
|
1.7x
|
| Price / FCF |
22.1x
|
23.5x
|
| Revenue Growth YoY |
+12.4%
|
+6.5%
|
| Gross Margin |
70.7%
|
37.2%
|
| Operating Margin |
27.6%
|
15.5%
|
| Return on Equity |
68.0%
|
10.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
4.26%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
The Walt Disney Company operates as a leading global entertainment and media conglomerate with a strong brand portfolio and diversified revenue streams across media networks, parks, experiences, and studio entertainment. The business quality is medium due to its durable brand and intangible assets but recent earnings pressure with a 31.4% decline in earnings in the most recent quarter highlights …
Accumulation Zones
| Metric |
ABBV |
DIS |
| Zone Low |
$198.23 |
$104.57 |
| Zone High |
$224.66 |
$118.52 |
| In Buy Zone? |
No
|
Yes
|